Comprehensive benchmarking of computational methods for the prognostic significance of tumour-infiltrating lymphocytes (TILs) in breast cancer remains elusive. Here, the authors perform multi-centric validation and evaluation of multiple cTILs methods in a large cohort of triple negative and HER2+ breast cancer patients.
- Mart van Rijthoven
- Witali Aswolinskiy
- Kyungdoc Kim
